Fortress Biotech, Inc. (FBIOP) Receivables - Other (2014 - 2023)

Fortress Biotech (FBIOP) posted quarterly Receivables - Other of $100000.0 for Q4 2023, down 66.67% quarter-over-quarter from $300000.0 in Q1 2023.

Fortress Biotech, Inc. (FBIOP) Receivables - Other (2014 - 2023) Analysis & Trends

Fortress Biotech's Receivables - Other history runs 10 years deep, the most recent figure standing at $100000.0 for Q4 2023.

In Q4 2023, Receivables - Other changed N/A year-over-year to $100000.0; the TTM figure through Dec 2023 stood at $100000.0 (changed N/A YoY), while the FY2023 annual figure was $100000.0, changed N/A from the prior year.
Receivables - Other for Q4 2023 stood at $100000.0, down from $300000.0 in the prior quarter.
The five-year high for Receivables - Other was $400000.0 in Q2 2021, with the low at $100000.0 in Q1 2019.
The 5-year median for Receivables - Other is $100000.0 (2019), against an average of $172727.3.
The sharpest annual moves came in 2019 and 2021: Receivables - Other sank 94.13% in 2019, then soared 300.0% in 2021.
Fortress Biotech's Receivables - Other stood at $100000.0 in 2019, then changed by 0.0% to $100000.0 in 2020, then jumped by 300.0% to $400000.0 in 2021, then slumped by 75.0% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023.
Business Quant data shows FBIOP's Receivables - Other at $100000.0 in Q4 2023, $300000.0 in Q1 2023, and $100000.0 in Q1 2022.

Download Data